» Articles » PMID: 27677924

Selective Activation of Vascular K 7.4/K 7.5 K Channels by Fasudil Contributes to Its Vasorelaxant Effect

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2016 Sep 29
PMID 27677924
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: K 7 (K 7.1-7.5) channels play an important role in the regulation of neuronal excitability and the cardiac action potential. Growing evidence suggests K 7.4/K 7.5 channels play a crucial role in regulating vascular smooth muscle contractility. Most of the reported K 7 openers have shown poor selectivity across these five subtypes. In this study, fasudil - a drug used for cerebral vasospasm - has been found to be a selective opener of K 7.4/K 7.5 channels.

Experimental Approach: A perforated whole-cell patch technique was used to record the currents and membrane potential. Homology modelling and a docking technique were used to investigate the interaction between fasudil and the K 7.4 channel. An isometric tension recording technique was used to assess the vascular tension.

Key Results: Fasudil selectively and potently enhanced K 7.4 and K 7.4/K 7.5 currents expressed in HEK293 cells, and shifted the voltage-dependent activation curve in a more negative direction. Fasudil did not affect either K 7.2 and K 7.2/K 7.3 currents expressed in HEK293 cells, the native neuronal M-type K currents, or the resting membrane potential in small rat dorsal root ganglia neurons. The Val in S5 and Ile in S6 segment of K 7.4 were critical for this activating effect of fasudil. Fasudil relaxed precontracted rat small arteries in a concentration-dependent fashion; this effect was antagonized by the K 7 channel blocker XE991.

Conclusions And Implications: These results suggest that fasudil is a selective K 7.4/K 7.5 channel opener and provide a new dimension for developing selective K 7 modulators and a new prospective for the use, action and mechanism of fasudil.

Citing Articles

Intratracheally Administered Peptide-Modified Lipid Admixture Containing Fasudil and/or DETA NONOate Ameliorates Various Pathologies of Pulmonary Arterial Hypertension.

Sarkar T, Moinuddin S, Isbatan A, Chen J, Mann D, Ahsan F Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139783 PMC: 10747237. DOI: 10.3390/ph16121656.


Activation of Kv7 channels normalizes hyperactivity of the VTA-NAcLat circuit and attenuates methamphetamine-induced conditioned place preference and sensitization in mice.

Liu E, Pang K, Liu M, Tan X, Hang Z, Mu S Mol Psychiatry. 2023; 28(12):5183-5194.

PMID: 37604975 DOI: 10.1038/s41380-023-02218-5.


Repressor element 1-silencing transcription factor deficiency yields profound hearing loss through K7.4 channel upsurge in auditory neurons and hair cells.

Zhang H, Li H, Lu M, Wang S, Ma X, Wang F Elife. 2022; 11.

PMID: 36125121 PMC: 9525063. DOI: 10.7554/eLife.76754.


Behavior of KCNQ Channels in Neural Plasticity and Motor Disorders.

Singh S, William M, Malavia M, Chu X Membranes (Basel). 2022; 12(5).

PMID: 35629827 PMC: 9143857. DOI: 10.3390/membranes12050499.


Activation of KCNQ4 as a Therapeutic Strategy to Treat Hearing Loss.

Rim J, Choi J, Jung J, Gee H Int J Mol Sci. 2021; 22(5).

PMID: 33801540 PMC: 7958948. DOI: 10.3390/ijms22052510.


References
1.
Schenzer A, Friedrich T, Pusch M, Saftig P, Jentsch T, Grotzinger J . Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. J Neurosci. 2005; 25(20):5051-60. PMC: 6724866. DOI: 10.1523/JNEUROSCI.0128-05.2005. View

2.
Liu B, Linley J, Du X, Zhang X, Ooi L, Zhang H . The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl- channels. J Clin Invest. 2010; 120(4):1240-52. PMC: 2846053. DOI: 10.1172/JCI41084. View

3.
Blom S, Schmitt N, Jensen H . Differential effects of ICA-27243 on cloned K(V)7 channels. Pharmacology. 2010; 86(3):174-81. DOI: 10.1159/000317525. View

4.
Xiong Q, Sun H, Li M . Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants. Nat Chem Biol. 2007; 3(5):287-96. DOI: 10.1038/nchembio874. View

5.
Lange W, Geissendorfer J, Schenzer A, Grotzinger J, Seebohm G, Friedrich T . Refinement of the binding site and mode of action of the anticonvulsant Retigabine on KCNQ K+ channels. Mol Pharmacol. 2008; 75(2):272-80. DOI: 10.1124/mol.108.052282. View